HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.

Abstract
In the majority of human malignancies, maintenance of telomeres is achieved by reactivation of telomerase, whereas a smaller fraction uses an alternative telomere lengthening (ALT) mechanism. Here, we used 16 non-small cell lung cancer (NSCLC) cell lines to investigate telomere stabilization mechanisms and their effect on tumor aggressiveness. Three of 16 NSCLC cell lines (VL-9, SK-LU-1, and VL-7) lacked telomerase activity, correlating with significantly reduced tumorigenicity in vitro and in vivo. Of the three telomerase-negative cell lines, only SK-LU-1 displayed characteristics of an ALT mechanism (i.e., highly heterogeneous telomeres and ALT-associated promyelocytic leukemia bodies). VL-9 cells gained telomerase during in vitro propagation, indicating incomplete immortalization in vivo. In contrast, NSCLC metastasis-derived VL-7 cells remained telomerase and ALT negative up to high passage numbers and following transplantation in severe combined immunodeficient mice. Telomeres of VL-7 cells were homogeneously short, and chromosomal instability (CIN) was comparable with most telomerase-positive cell lines. This indicates the presence of an efficient telomere stabilization mechanism different from telomerase and ALT in VL-7 cells. To test the effect of ectopic telomerase reverse transcriptase (hTERT) in these unique ALT- and telomerase-negative tumor backgrounds, hTERT was transfected into VL-7 cells. The activation of telomerase led to an excessively rapid gain of telomeric sequences resulting in very long ( approximately 14 kb), uniform telomeres. Additionally, hTERT expression induced a more aggressive growth behavior in vitro and in vivo without altering the level of CIN. These data provide further evidence for a direct oncogenic activity of hTERT not based on the inhibition of CIN.
AuthorsAndreas Brachner, Soleman Sasgary, Christine Pirker, Chantal Rodgarkia, Mario Mikula, Wolfgang Mikulits, Helga Bergmeister, Ulrike Setinek, Matthias Wieser, Suet-Feung Chin, Carlos Caldas, Michael Micksche, Christa Cerni, Walter Berger
JournalCancer research (Cancer Res) Vol. 66 Issue 7 Pg. 3584-92 (Apr 01 2006) ISSN: 0008-5472 [Print] United States
PMID16585183 (Publication Type: Journal Article)
Chemical References
  • DNA-Binding Proteins
  • Telomerase
Topics
  • Animals
  • Carcinoma, Non-Small-Cell Lung (enzymology, genetics, pathology)
  • Cell Growth Processes (genetics)
  • Cell Line, Tumor
  • DNA-Binding Proteins (biosynthesis, genetics, pharmacology, physiology)
  • HeLa Cells
  • Humans
  • Lung Neoplasms (enzymology, genetics, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Mice, SCID
  • Telomerase (biosynthesis, deficiency, genetics, metabolism, pharmacology, physiology)
  • Telomere
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: